Venetoclax-containing Therapy Combined With Microtransplant for Newly Diagnosed AML
Primary endpoint(s) modified
Beijing 302 HospitalPhase 2 NCT07078591 Registry history of NCT07078591 on ClinicalTrials.gov (opens the registry)
3 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 2 with minor changes only.
Primary endpoint(s) modified
Beijing 302 HospitalPhase 2 NCT07078591 Registry history of NCT07078591 on ClinicalTrials.gov (opens the registry)
Registry marked status Unknown (sponsor has not verified the record since Apr 2024); last known: Not Yet Recruiting
Beijing 302 HospitalPhase 1 NCT06364787 Registry history of NCT06364787 on ClinicalTrials.gov (opens the registry)
Changed
Registry marked status Unknown (sponsor has not verified the record since Apr 2024); last known: Not Yet Recruiting
Beijing 302 HospitalEarly Phase 1 NCT06364800 Registry history of NCT06364800 on ClinicalTrials.gov (opens the registry)
Changed
Registry verification sweep
Changed
| Phase 1 | 1 | |
| Phase 1/2 | 3 | |
| Phase 2 | 9 | |
| Phase 4 | 1 |
Leukemia (5) · Acute Myeloid Leukemia (AML) (4) · Breast Cancer (3) · Myelodysplastic Syndromes (MDS) (2)